The kinin-kallikrein system (KKS) is an endogenous multiprotein cascade, the activation of which leads to triggering of the intrinsic coagulation pathway and enzymatic hydrolysis of kininogens with the consequent release of bradykinin-related peptides. This system plays a crucial role in inflammation, vasodilation, smooth muscle contraction, cardioprotection, vascular permeability, blood pressure control, coagulation and pain. In this review, we will outline the physiology and pathophysiology of the KKS and also highlight the association of this system with carcinogenesis and cancer progression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/1354750X.2013.787544 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patterns of C1-Inhibitor Plasma Levels and Kinin-Kallikrein System Activation in Relation to COVID-19 Severity.
Life (Basel)
November 2024
Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, 20157 Milan, Italy.
Background: Although more than four years have passed since the pandemic began, SARS-CoV-2 continues to be of concern. Therefore, research into the underlying mechanisms that contribute to the development of the disease, especially in more severe forms, remains a priority. Sustained activation of the complement (CS), contact (CAS), and fibrinolytic and kinin-kallikrein systems (KKS) has been shown to play a central role in the pathogenesis of the disease.
View Article and Find Full Text PDFAprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.
Int J Mol Sci
July 2024
Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, 13971 Ciudad Real, Spain.
Proteases are produced and released in the mucosal cells of the respiratory tract and have important physiological functions, for example, maintaining airway humidification to allow proper gas exchange. The infectious mechanism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), takes advantage of host proteases in two ways: to change the spatial conformation of the spike (S) protein via endoproteolysis (e.g.
View Article and Find Full Text PDFAprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.
Int J Mol Sci
June 2024
Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, 13971 Ciudad Real, Spain.
Aprotinin is a broad-spectrum inhibitor of human proteases that has been approved for the treatment of bleeding in single coronary artery bypass surgery because of its potent antifibrinolytic actions. Following the outbreak of the COVID-19 pandemic, there was an urgent need to find new antiviral drugs. Aprotinin is a good candidate for therapeutic repositioning as a broad-spectrum antiviral drug and for treating the symptomatic processes that characterise viral respiratory diseases, including COVID-19.
View Article and Find Full Text PDFMast cell degranulation and bradykinin-induced angioedema - searching for the missing link.
Front Immunol
May 2024
Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Article Synopsis
- Initiation of the bradykinin cascade can cause angioedema attacks without wheals, particularly in hereditary angioedema due to C1 inhibitor deficiency (HAE-C1-INH), highlighting a complex interplay between mast cells and this process.
- * Recent findings suggest mast cell degranulation might activate the kallikrein-kinin system, leading to bradykinin formation, while also revealing a connection between bradykinin and histamine symptoms, despite their distinct clinical presentations.
- * Exploring mast cell-related receptors, specifically MRGPRX2, and their ligands could help understand individual variability in HAE-C1-INH responses, raising important questions about potential therapeutic interventions targeting mast cell activation versus br
Kinin-kallikrein system: New perspectives in heart failure.
Heart Fail Rev
May 2024
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Heart failure (HF) is a pervasive clinical challenge characterized by compromised cardiac function and reduced quality of life. The kinin-kallikrein system (KSS), a multifaceted peptide cascade, has garnered substantial attention due to its potential role in HF. Through activation of B1 and/or B2 receptors and downstream signaling, kinins modulate various physiological processes, including inflammation, coagulation, pain, blood pressure control, and vascular permeability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!